Abstract
Pre-eclampsia is a pregnancy-specific disorder that causes a high degree of maternal and fetal morbidity and mortality. Despite many recent advances in the field, the diagnosis, treatment and prevention of pre-eclampsia remain elusive. The current patent application provides evidence for a marker of pre-eclampsia, a 26.6-kDa polypeptide, which is present in pre-eclamptic women and absent in normal controls. The prospect of developing a laboratory test for the diagnosis of pre-eclampsia is exciting, as is the possibility for risk-stratification and potential therapies.
Original language | English (US) |
---|---|
Pages (from-to) | 299-302 |
Number of pages | 4 |
Journal | Expert Opinion on Medical Diagnostics |
Volume | 1 |
Issue number | 2 |
DOIs | |
State | Published - Oct 2007 |
Keywords
- diagnosis
- hypertension
- pre-eclampsia
- prediction
ASJC Scopus subject areas
- Biomedical Engineering
- Molecular Medicine
- Biochemistry, medical